NABRIVA THERAPEUTICS AG - SPONSORED ADR (NBRV)

CUSIP: 62957M104

Q4 2015 13F Holders as of 31 Dec 2015

Type / Class
Equity / SPONSORED ADR
Total 13F shares
9,813,433
Share change
+99,241
Total reported value
$194,778,000
Price per share
$9.60
Number of holders
21
Value change
-$2,104,093
Number of buys
10
Number of sells
9

Quarterly Holders Quick Answers

What is CUSIP 62957M104?
CUSIP 62957M104 identifies NBRV - NABRIVA THERAPEUTICS AG - SPONSORED ADR in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NABRIVA THERAPEUTICS AG - SPONSORED ADR (NBRV) as of Q4 2015

As of 31 Dec 2015, NABRIVA THERAPEUTICS AG - SPONSORED ADR (NBRV) was held by 21 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 9,813,433 shares. The largest 10 holders included WELLINGTON MANAGEMENT GROUP LLP, ORBIMED ADVISORS LLC, WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST, Omega Fund Management, LLC, Novo A/S, EcoR1 Capital, LLC, ACUTA CAPITAL PARTNERS, LLC, FRANKLIN RESOURCES INC, BAKER BROS. ADVISORS LP, and Rock Springs Capital Management LP. This page lists 21 institutional shareholders reporting positions in this security for the Q4 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.